Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$53.17−2.96 (-5.27%)
Close on Nov 16, 2026Market cap $7.39BP/E –Yield –
Cytokinetics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Cytokinetics's EV/EBITDA was 45.7× on Jul 31, 2017, against 4.5× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2017 | Jul 31, 2017 | 45.7× | −118.9 |
| 2016 | Dec 30, 2016 | 164.6× | +161.6 |
| 2011 | Jan 31, 2011 | 3.0× | −0.4 |
| 2010 | Dec 31, 2010 | 3.4× | – |
See a number that looks wrong?